What are the challenges of gene therapy for neurological disorders?
Updated: Oct 5
Gene therapy holds great promise for treating neurological disorders, but it faces several key challenges:
Blood-Brain Barrier (BBB): The BBB restricts the delivery of therapeutic agents, complicating the transport of gene therapy vectors to the brain.
Cell Targeting: Neurological disorders involve specific neuron types, making precise targeting critical for effective treatment.
Disease Heterogeneity: The diverse nature of neurological disorders complicates the development of one-size-fits-all gene therapies.
Long-Term Effects: The long-term safety and efficacy of gene therapies in the central nervous system (CNS) remain uncertain, requiring extensive research.
Ethical and Regulatory Issues: Stringent regulations ensure safety but can slow the pace of innovation in gene therapy.
Cost and Accessibility: High costs hinder access to these therapies for many patients, necessitating ongoing efforts to improve affordability.
Got more to add on this topic? Share your thoughts in the comments below!
Keep exploring with Gene Tech Times
Free guide: subscribe to the Gene Tech Times Briefing on our homepage and get Every FDA-Approved Gene Therapy at a Glance in your inbox.
Watch: 30-second gene therapy Shorts on Gene Tech Times Academy.
Read: The Cheat Codes of Our Genes, real stories of mutations that make some people immune to disease.
New to gene therapy? Start with The Life-Changing Power of Gene Therapy.
As an Amazon Associate, Gene Tech Times earns from qualifying purchases.
Comments